STAMPEDE provides further insight into treating prostate cancer
Active observation still the best treatment for kidney cancer patients at medium or high risk of their cancer coming back after surgery
More men with prostate cancer can be spared radiotherapy after surgery
ESMO Congress 2019
This Friday marks the beginning of the ESMO Congress 2019, where MRC Clinical Trials Unit at UCL will be presenting results from prostate and kidney cancer trials. The ESMO Congress brings together a large number of oncology professionals from across Europe. It will take place from Friday 27 September - Tuesday 1 Oct in Barcelona, Spain. Details of the MRC CTU at UCL presenta ...
Antibiotic prophylaxis and multi-vitamin multi-mineral supplements provide no benefit for children with severe anaemia